Evoke Pharma

$0.92
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

$0.00 (0.00%) Today
$0.00 (0.00%) As of 3:59 PM EDT after-hours

Why Robinhood?

You can buy or sell Evoke Pharma and other stocks, options, ETFs, and crypto commission-free!

About EVOK

Evoke Pharma, Inc. Common Stock, also called Evoke Pharma, is a pharmaceutical company, which engages in the development of drugs for the treatment of gastrointestinal disorders and diseases. Read More It develops Gimoti, with promotility and anti-emetic effects, for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women with diabetes mellitus. The company was founded by Matthew J. D'Onofrio, Cam L. Garner, Scott L. Glenn, and David A. Gonyer in January 2007 and is headquartered in Solana Beach, CA.

Employees
6
Headquarters
Solana Beach, California
Founded
2007
Market Cap
22.18M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
203.34K
High Today
$0.92
Low Today
$0.89
Open Price
$0.9088
Volume
84.73K
52 Week High
$3.40
52 Week Low
$0.5001

Collections

EVOK News

BenzingaJul 25

Evoke Pharma, iShares NASDAQ Biotechnology Index Fund - Biotech Stock On The Radar: Evoke Pharma Sets Date With FDA

1,837

EVOK Earnings

-$0.23
-$0.18
-$0.12
-$0.07
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Estimated
Actual
Expected Nov 13, Pre-Market

More EVOK News

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.